Thus, our study not only identifies PHF2-S655 phosphorylation as a biomarker for the prediction of tumor metastasis but also provides the evidence that PHF2 activation maybe a promising strategy for tackling lung cancer metastasis. The gene discussed is PHF2; the disease is lung cancer.